CPRX (STOCKS)
Catalyst Pharmaceutical Inc.
$31.340000
-0.020000 (-0.06%)
Prev close: $31.360000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Richard John Daly
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,840.32M
- Employees
- 167
- P/E (TTM)
- 18.03
- P/B (TTM)
- 3.78
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
6
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.50 | $0.47 | +0.0349 | +7.50% |
|
Dec 2025 (Q4)
|
$0.41 | $0.34 | +0.0673 | +19.64% |
|
Sep 2025 (Q3)
|
$0.42 | $0.34 | +0.0814 | +24.04% |
|
Jun 2025 (Q2)
|
$0.41 | $0.39 | +0.0163 | +4.14% |
Financial Statements
| Revenues | $596.96M |
| Benefits Costs and Expenses | $300.50M |
| Cost Of Revenue | $83.82M |
| Costs And Expenses | $300.50M |
| Gross Profit | $513.14M |
| Operating Expenses | $207.64M |
| Selling, General, and Administrative Expenses | $196.16M |
| Research and Development | $11.48M |
| Operating Income/Loss | $267.64M |
| Income/Loss From Continuing Operations After Tax | $221.32M |
| Income/Loss From Continuing Operations Before Tax | $296.46M |
| Income Tax Expense/Benefit | $75.14M |
| Net Income/Loss | $221.32M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $221.32M |
| Net Income/Loss Available To Common Stockholders, Basic | $221.32M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.81 |
| Diluted Earnings Per Share | $1.74 |
| Basic Average Shares | 367,226,065 |
| Diluted Average Shares | 381,592,844 |
| Assets | $1.15B |
| Current Assets | $940.39M |
| Inventory | $34.93M |
| Other Current Assets | $905.46M |
| Noncurrent Assets | $207.22M |
| Fixed Assets | $994.00K |
| Other Non-current Assets | $206.23M |
| Liabilities | $134.91M |
| Current Liabilities | $132.40M |
| Accounts Payable | $7.15M |
| Wages | $6.53M |
| Other Current Liabilities | $118.72M |
| Noncurrent Liabilities | $2.52M |
| Equity | $1.01B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.01B |
| Liabilities And Equity | $1.15B |
| Net Cash Flow From Operating Activities | $208.21M |
| Net Cash Flow From Operating Activities, Continuing | $208.21M |
| Net Cash Flow From Investing Activities | $63.02M |
| Net Cash Flow From Investing Activities, Continuing | $63.02M |
| Net Cash Flow From Financing Activities | -$32.93M |
| Net Cash Flow From Financing Activities, Continuing | -$32.93M |
| Net Cash Flow | $238.31M |
| Net Cash Flow, Continuing | $238.31M |
| Comprehensive Income/Loss | $221.35M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $221.35M |
| Other Comprehensive Income/Loss | $25.00K |